ELAN
ELAN
NYSE · Pharmaceuticals

Elanco Animal Health Inc

$25.74
+2.06 (+8.70%)
As of Nov 7, 9:48 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +573.0% upside
Low Target $121.49
Average Target $173.23
High Target $230.47
Current Price $25.74
Current
$25.74
Target
$173.23
$121.49 $173.23 avg $230.47
Scenario Analysis
Bear Case
$121.49
372.0%
Low target
Base Case
$173.23
+573.0%
Avg target
Bull Case
$230.47
+795.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$27.98
-8.0% from high
52-Week Low
$19.40
+32.7% from low
50-Day SMA
$23.13
+11.3% vs SMA
200-Day SMA
$23.80
+8.2% vs SMA
RSI (14)
62.9
Neutral
Target vs 52W High
$173.23
+519.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%